Sign up for Englemed updates from TwitterSign up for Englemed updates from Facebook
Contact Englemed
Our contact email address.
We can provide a specialist, tailored health and medical news service for your site.
Click here for more information
RSS graphic XML Graphic Add to Google
About Englemed news services - services and policies.
Englemed News Blog - Ten years and counting.
Diary of a reluctant allergy sufferer - How the British National Health Service deals with allergy.
BookshopFor books on women's health, healthy eating ideas, mental health issues, diabetes, etc click here

WWW Englemed
Copyright Notice. All reports, text and layout copyright Englemed Ltd, 52 Perry Avenue, Birmingham UK B42 2NE. Co Registered in England No 7053778 Some photos copyright Englemed Ltd, others may be used with permission of copyright owners.
Disclaimer: Englemed is a news service and does not provide health advice. Advice should be taken from a medical professional or appropriate health professional about any course of treatment or therapy.
Metformin could be a treatment for women with pre-eclampsia
Thurs September 23rd - Metformin shows promise as a treatment for preterm pre-eclampsia, a study reveals today. More
AI identifies possible drug combination for brain cancer
Thurs September 23rd - Artificial intelligence-enhanced tools have been used to identify a new combination of drugs that could treat a rare and incurable childhood brain cancer. More
On 09/10/2020 William Haworth wrote:
How long is recovery time after proceedure... on Ablation cuts atrial fibrillat...
On 08/02/2018 David Kelly wrote:
Would you like to write a piece about this to be i... on Researchers unveil new pain re...
On 23/10/2017 Cristina Pereira wrote: on HIV breakthrough - MRC...
On 12/09/2017 Aparna srikantam wrote:
Brilliant finding! indeed a break through in under... on Leprosy research breakthrough...
On 01/07/2017 Annetta wrote:
I have been diagnosed with COPD for over 12 years.... on Seaweed plan for antimicrobial...

Eye surface changes could identify long COVID

Tuesday July 27th 2021

Long COVID could be identified by nerve fibre loss and an increase in dendritic cells on the cornea, doctors suggest today.

The observational study found the changes were seen particularly among those with neurological symptoms, such as loss of taste and smell, headache, dizziness, numbness, and neuropathic pain.

The team, which involved researchers from Necmettin Erbakan University Meram Medical Faculty Hospital, Konya, Turkey, Weill Cornell Medicine-Qatar, Doha, and the Institute of Cardiovascular Sciences at the University of Manchester and NIHR Clinical Research Facility, Manchester, UK, used corneal confocal microscopy (CCM) to pick up nerve damage in the cornea.

CCM has been used to identify nerve damage and inflammatory changes attributable to diabetic neuropathy, multiple sclerosis, and fibromyalgia.

The research involved 40 people who had recovered from confirmed COVID-19 infection between one and six months earlier and they completed a NICE questionnaire, comprising 28 items in nine domains: generalised, respiratory, cardiovascular, neurological, musculoskeletal, psychological/psychiatric, gastrointestinal, dermatological, and ear, nose and throat symptoms, with a score ranging from 0 to 28.

Writing in the British Journal of Ophthalmology, the team says neurological symptoms were present at four and 12 weeks in 22 out of 40 patients (55%) and 13 out of 29 (45%) patients, respectively.

Participants’ corneas were scanned using CCM to look for small nerve fibre damage and the density of dendritic cells, which have a key role in the primary immune system response by capturing and presenting antigens from invading organisms and were compared with those of 30 healthy people who had not had COVID-19.

They found 22 (55%) of the 40 COVID patients had no clinical signs of pneumonia; 11 (28%) had clinical signs of pneumonia not requiring oxygen therapy; four (10%) had been admitted to hospital with pneumonia and received oxygen therapy; and three (8%) with pneumonia had been admitted to the intensive care.

The corneal scans revealed that patients with neurological symptoms four weeks after they had recovered from acute COVID-19 had greater corneal nerve fibre damage and loss, with higher numbers of dendritic cells, than those who had not had COVID-19 infection.

Those without neurological symptoms had comparable numbers of corneal nerve fibres as those who had not been infected with COVID-19, but higher numbers of dendritic cells.

Although this was an observational study with a small number of participants and no long-term monitoring, the researchers write: “To the best of our knowledge, this is the first study reporting corneal nerve loss and an increase in [dendritic cell] density in patients who have recovered from COVID-19, especially in subjects with persisting symptoms consistent with long COVID.”

“We show that patients with long COVID have evidence of small nerve fibre damage which relates to the severity of long COVID and neuropathic as well as musculoskeletal symptoms.”

They say that CCM could be used as a rapid objective ophthalmic test to evaluate patients with long COVID.

Bitirgen G, Korkmaz C, ZAmani A et al. Corneal confocal microscopy identifies corneal nerve fibre loss and increased dendritic cells in patients with long COVID. British Journal of Ophthalmology 27 July 2021; doi 10.1136/bjophthalmol-2021-319450


Tags: Asia | Eye Health | Flu & Viruses | UK News

Printer friendly page Printer friendly page

Comment on this article:

<a>,<b> & <p> tags allowed
Please enter the letters displayed:
(not case sensitive)